Interim Clinical Guidance for the Implementation of Injectable-Free Regimens for Rifampicin-Resistant Tuberculosis in Adults, Adolescents and Children
Ministry of Health, South Africa
This guidance outlines the interim clinical guidelines on the implementation of the modified short and long treatment regimens for people with Rifampicin Resistant Tuberculosis (RR-TB) in South Africa.
Process Flow
Compare Versions
Please select two versions
Interim Clinical Guidance for the Implementation of Injectable-Free Regimens for Rifampicin-Resistant Tuberculosis in Adults, Adolescents and Children Current Version
January 2022
This guidance outlines the interim clinical guidelines on the implementation of the modified short and long treatment regimens for people with Rifampicin Resistant Tuberculosis (RR-TB) in South Africa.
Thank you for requesting an expert analysis
A member of our team will review your request and reply back to the email address on file.